Literature DB >> 29399141

Cancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer.

Qian Zhang1, Chunwei Peng2.   

Abstract

Gastric cancer (GC) is a frequently diagnosed type of cancer in China, and is associated with a high mortality rate. The biological behavior of GC requires investigation in order to provide an evidence base for the development of strategies to prevent and treat GC. For this purpose, the present review outlines the process of tumor microenvironment (TME) evolution, including the dynamic biological behavior of different types of cancer cell and stroma. Cancer-associated fibroblasts (CAFs) serve as prominent stromal cellular components in the GC TME, and exhibit an essential function in GC progression. In the present study, the function of CAFs in cancer cell proliferation, cell migration, invasion, extracellular matrix remodeling, pathological angiogenesis and immune cell infiltration were investigated. The studies discussed in the present review demonstrate that the cross-talk between CAF, cancer cells and tumor stroma promotes GC progression.

Entities:  

Keywords:  angiogenesis; cancer-associated fibroblast; gastric cancer; tumor microenvironment; vascular endothelial growth factor

Year:  2017        PMID: 29399141      PMCID: PMC5772670          DOI: 10.3892/ol.2017.7385

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  103 in total

1.  Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer.

Authors:  Chun-Wei Peng; Qian Tian; Gui-Fang Yang; Min Fang; Zhi-Ling Zhang; Jun Peng; Yan Li; Dai-Wen Pang
Journal:  Biomaterials       Date:  2012-05-16       Impact factor: 12.479

2.  Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.

Authors:  Florian Weber; Scott N Byrne; Shery Le; David A Brown; Samuel N Breit; Richard A Scolyer; Gary M Halliday
Journal:  Cancer Immunol Immunother       Date:  2005-03-18       Impact factor: 6.968

3.  Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.

Authors:  Neta Erez; Sarah Glanz; Yael Raz; Camilla Avivi; Iris Barshack
Journal:  Biochem Biophys Res Commun       Date:  2013-07-02       Impact factor: 3.575

Review 4.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

Review 5.  Clinical implications of circulating angiogenic factors in cancer patients.

Authors:  R T Poon; S T Fan; J Wong
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

6.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.

Authors:  Dong Tang; Jun Gao; Sen Wang; Nianyuan Ye; Yang Chong; Yuqin Huang; Jie Wang; Bin Li; Wei Yin; Daorong Wang
Journal:  Tumour Biol       Date:  2015-09-01

Review 8.  Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.

Authors:  Urszula M Polanska; Akira Orimo
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

9.  FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells.

Authors:  Chao Sun; Hirokazu Fukui; Ken Hara; Xinxing Zhang; Yoshitaka Kitayama; Hirotsugu Eda; Toshihiko Tomita; Tadayuki Oshima; Shojiro Kikuchi; Jiro Watari; Mitsuru Sasako; Hiroto Miwa
Journal:  BMC Cancer       Date:  2015-04-30       Impact factor: 4.430

Review 10.  MicroRNA regulons in tumor microenvironment.

Authors:  H I Suzuki; A Katsura; H Matsuyama; K Miyazono
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

View more
  12 in total

1.  Cancer Stem Cells: An Ever-Hiding Foe.

Authors:  Jacek R Wilczyński
Journal:  Exp Suppl       Date:  2022

Review 2.  Gastric cancer: a comprehensive review of current and future treatment strategies.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Maria Diab; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2020-09-07       Impact factor: 9.264

3.  Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.

Authors:  Jiuyang Liu; Chaoqun Huang; Chunwei Peng; Fei Xu; Yan Li; Yonemura Yutaka; Bin Xiong; Xiaojun Yang
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430

Review 4.  Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.

Authors:  Ladan Mashouri; Hassan Yousefi; Amir Reza Aref; Ali Mohammad Ahadi; Fatemeh Molaei; Suresh K Alahari
Journal:  Mol Cancer       Date:  2019-04-02       Impact factor: 27.401

Review 5.  Emerging insights into the biology of metastasis: A review article.

Authors:  Soussan Irani
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

Review 6.  Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies.

Authors:  Zhengyang Yang; Wei Deng; Xiao Zhang; Yongbo An; Yishan Liu; Hongwei Yao; Zhongtao Zhang
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

7.  A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.

Authors:  Yan Jia; Quan Tian; Kaitai Yang; Yi Liu; Yanfeng Liu
Journal:  Biomed Res Int       Date:  2021-11-20       Impact factor: 3.411

8.  Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.

Authors:  Katharina Kessel; Robert Seifert; Matthias Weckesser; Martin Boegemann; Sebastian Huss; Clemens Kratochwil; Uwe Haberkorn; Frederik Giesel; Kambiz Rahbar
Journal:  Ann Nucl Med       Date:  2021-12-02       Impact factor: 2.668

Review 9.  Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.

Authors:  Donatella Aldinucci; Naike Casagrande
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

10.  Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer.

Authors:  Yongchen Ma; Jing Zhu; Shanwen Chen; Tengyu Li; Ju Ma; Shihao Guo; Jianwen Hu; Taohua Yue; Junling Zhang; Pengyuan Wang; Xin Wang; Guowei Chen; Yucun Liu
Journal:  Cancer Cell Int       Date:  2018-07-20       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.